Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials

• Principais autores: Shi-Bing Liang (Autor), Min Fang (Autor), Chang-Hao Liang (Autor), Hui-Di Lan (Autor), Chen Shen (Autor), Li-Jiao Yan (Autor), Xiao-Yang Hu (Autor), Mei Han (Autor), Nicola Robinson (Autor), Jian-Ping Liu (Autor)
• Formato: Livro
• Publicado em: Elsevier, 2021-08-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Introduction: Chinese patent medicine (CPM) is an indispensable part of traditional Chinese medicine. Coronavirus Disease 2019 (COVID-19) manifests is an acute respiratory infectious disease. This systematic review aimed to evaluate the therapeutic effects and safety of oral CPM for COVID-19. Method...